Every value below carries the sentence it was read from.
35 sources stand behind the page.
Field
Value
Cited text
Known as
CAR-T cells
“Subjects will receive (0.6-60)x10E8 transduced CART cells as a split dose over three days as follows: Day 0, 10% fraction: (0.06-6)x10E8 CART19 cells, Day 1, 30% fraction:...” NCT03767725 ↗27
“a novel method for treatment of multiple myeloma, in which patients' T cells are engineered into B Cell Maturation Antigen（BMCA）-Targeted CAR-T cells to eliminate myeloma cells.” NCT03931421 ↗
“This intervention involves the infusion of autologous or allogeneic CAR-T cells into patients with relapsed/refractory hematologic malignancies.” NCT06849921 ↗
“The name of the drug is CAR gene-modified T cells or abbreviated as EGFRvIII CARs.” NCT02664363 ↗
Known as
EGFRvIII-CAR T Cells
“The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma.” NCT05063682 ↗
Known as
EGFRvIII-CARs
ClinicalTrials.gov intervention name — accepted as the source's own labelNCT03283631 ↗
Known as
Second generation CAR-T cells
ClinicalTrials.gov intervention name — accepted as the source's own labelNCT03366324 ↗1
“The trained cells are called CD30.CAR T cells. Then, the cells will be tested to make sure that they kill lymphoma cells that express the CD30 antigen and not normal cells.” NCT02917083 ↗
Modality
Cell therapy
“chimeric antigen receptor (CAR)-modified T cells” NCT02186860 ↗
Route
Intravenous
“a single dose of 1 million CAR-T cells per kg will be administrated intravenously” PMID 28039295 ↗Dec 2016